FTC Sues Hims & Hers Over Alleged User Data Sharing and Deceptive Billing

The U.S. Federal Trade Commission (FTC) is suing telehealth platform Hims & Hers Health, alleging the company illegally shared sensitive user health information with advertisers and engaged in deceptive business practices. The lawsuit, filed in conjunction with Los Angeles County and the state of Utah, targets the company's data privacy, billing, and subscription cancellation processes.

Details of the Allegations

According to an FTC spokesperson, the agency plans to allege that Hims & Hers broke its privacy promises by sharing user health data with third-party advertising companies. The complaint specifies that information was shared with firms including Meta Platforms and Snap through tracking technologies integrated into the Hims website.

The FTC also claims the company engaged in deceptive billing. The agency asserts that Hims & Hers charges customers for prescriptions after they fill out an intake form but before they have an opportunity for a consultation with a healthcare provider. The spokesperson noted that most customers do not receive a provider consultation before being charged.

Finally, the lawsuit alleges that Hims & Hers makes it unreasonably difficult for users to cancel their subscriptions, a practice that has drawn increased regulatory scrutiny across various industries.

Ad

Market Context and Implications

Hims & Hers is a prominent company in the telehealth sector, offering online consultations and direct-to-consumer prescriptions for conditions such as weight loss, hair loss, erectile dysfunction, and mental health. The news of the lawsuit had an immediate impact on the company's stock, which was trading down 10.85%.

This legal action signals heightened regulatory oversight of the rapidly growing telehealth industry, particularly concerning data privacy and consumer protection. For investors, the lawsuit presents significant risks, including potential fines, reputational damage, and the possibility of forced changes to the company's business model. The outcome could set a precedent for how consumer health data is handled by other digital health platforms.